US SR510 | 2023-2024 | 118th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 39-3)
Status: Introduced on December 14 2023 - 25% progression, died in committee
Action: 2023-12-14 - Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 14 2023 - 25% progression, died in committee
Action: 2023-12-14 - Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.
Title
A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-12-14 | Senate | Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004) |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-resolution/510/all-info |
| Text | https://www.congress.gov/118/bills/sres510/BILLS-118sres510is.pdf |
